Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SURF Surface Oncology Inc

1,07

0,00 (0,00%)

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Surface Oncology (NASDAQ:SURF)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Surface Oncology Charts.

Surface Oncology (NASDAQ:SURF)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Surface Oncology Charts.

News Surface Oncology Inc

Form EFFECT - Notice of Effectiveness
Mittwoch 13 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 September 2023 (8 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Donnerstag 31 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
Donnerstag 31 August 2023 (9 Monate vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mittwoch 30 August 2023 (9 Monate vor) • Edgar (US Regulatory)

Weitere Surface Oncology Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen